skip to Main Content

Novel Treatment Makes Pancreatic Cancer Susceptible to Immunotherapy, Mouse Study Shows

Newsfeed image, light gray text on dark gray background
Pancreatic cancer is one of the most aggressive and deadly tumor types and notorious for its resistance to virtually all types of treatment, including newer immunotherapies.

A new study — in mice — from Washington University School of Medicine in St. Louis suggests that blocking a major inflammatory pathway that is activated in pancreatic cancer makes the tumors sensitive to chemotherapy and a type of immunotherapy that prompts the immune system’s T cells to attack the cancer cells. The therapy more than doubled survival in a mouse model of pancreatic cancer. Read more . . . 


Back To Top